Comparative Effectiveness of Dual Therapy with Aspirin and Clopidogrel versus Aspirin Monotherapy for the Treatment of Ischemic Stroke at Takfa Hospital, Nakhon Sawan Province

Main Article Content

wasin netsuwan

Abstract

The purpose of this research was to study the effectiveness of treating ischemic stroke with aspirin combined with clopidogrel, comparing the effectiveness with using aspirin alone. This is a retrospective study, that analyzes causes to outcomes. Studied the incidence rate of stroke, Death due to stroke, Deaths from cerebrovascular causes including cardiovascular disease, and the occurrence of bleeding that requires hospital treatment through fluid administration or blood transfusion within 1 year after receiving treatment in stroke patients treated at Takfa Hospital during the period from 1 January 2018 to 1 January 2022. This research study used a case record form that the researcher created for use in data collection and research studies and passed the test. The accuracy of the content questionnaire (Content Validity) by experts. The data was analyzed using descriptive statistics and inferential statistics, analyzing multiple variables with multiple log-binomial regression analyses or multiple Poisson regression analyses, reported with Risk Ratio (RR) values as appropriate to the data. The results showed that treatment of ischemic stroke with aspirin plus clopidogrel. There was no statistical difference between treatment with aspirin alone.

Article Details

How to Cite
1.
netsuwan wasin. Comparative Effectiveness of Dual Therapy with Aspirin and Clopidogrel versus Aspirin Monotherapy for the Treatment of Ischemic Stroke at Takfa Hospital, Nakhon Sawan Province. JDPC3 [Internet]. 2024 Mar. 5 [cited 2024 Nov. 21];18(1):26-37. Available from: https://he01.tci-thaijo.org/index.php/JDPC3/article/view/268234
Section
OriginalArticle

References

World Stroke Organization Annual Report 2022 [Internet]. [cited 2023 Aug 12]. Available from: https://www.world-stroke.org/assets/downloads/WSO_Annual_Report_2022_-_online.pdf

World Stroke Organization. The top 10 causes of death [Internet]. 2022 [cited 2023 Aug 12]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death#.YhJBDXoc8HO

WSO Global Stroke Fact Sheet 2022 [Internet]. 2022 [cited 2023 Aug 12]. Available from: https://www.world-stroke.org/news-and-blog/news/wso-global-stroke-fact-sheet-2022

Ministry of Public Health strategy and planning division. Statistic of public health 2021.(in Thai)

Ministry of Public Health International Health Policy Program. Disability-Adjusted Life Year report 2019 [Internet]. Nonthaburi 11130:Handy press corperation 17/2 Bang Khanun Bang Kruai; 2023 [cited 2023 Aug 12].(in Thai) Available from: https://bit.ly/3GLtpsA

Ministry of Public Health Division of non communicable disease. Number and rate of death-illness 2016 - 2019 [Internet]. 2020 [cited 2023 Jul 26].(in Thai) Available from: https://bit.ly/48nRi54

Ministry of Public Health Nakhonsawan Provincal Public Heath Office. Rate of Stroke illness in Nakhonsawan [Internet]. [cited 2023 Aug 12].(in Thai) Available from: https://bit.ly/47WDLBQ

FAST method for screening stroke [Internet]. 2017 [cited 2023 Aug 12].(in Thai) Available from: https://www.hfocus.org/content/2017/10/14801

Wong KSL, Chen C, Fu J, Chang HM, Suwanwela NC, Huang YN, et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol. 2010 May;9(5):489–97.

Geeganage CM, Diener HC, Algra A, Chen C, Topol EJ, Dengler R, et al. Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke. 2012 Apr;43(4):1058–66.

Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. New England Journal of Medicine. 2013 Jul 4;369(1):11–9.

Hong KS, Lee SH, Kim EG, Cho KH, Chang D Il, Rha JH, et al. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke. Stroke. 2016 Sep;47(9):2323–30.

Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, et al. Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial. International Journal of Stroke. 2011 Feb 4;6(1):3–9.

Kim JT, Park MS, Choi KH, Cho KH, Kim BJ, Park JM, et al. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke. Stroke. 2019 Nov;50(11):3147–55.

Thai government gazette book 139 chapter 171. Announcement of National medical committee Average price of medicine [Internet]. 2022 [cited 2023 Jul 26].(in Thai) Available from: https://dmsic.moph.go.th/index/download/876

Ministry of Public Health Department of Medical services Neurological institute of Thailand. Stroke Handbook for Thai. 2013 [cited 2023 Jul 26];1–2.(in Thai) Available from: https://www.dms.go.th/backend//Content/Content_File/Old_Content/dmsweb/publish/publish28062019100655.pdf

Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. The Lancet. 2004 Jul;364(9431):331–7

Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, et al. Effect of Clopidogrel plus ASA vs. ASA Early after TIA and Ischaemic Stroke: A Substudy of the CHARISMA Trial. International Journal of Stroke. 2011 Feb 4;6(1):3–9.

Hong KS, Lee SH, Kim EG, Cho KH, Chang D Il, Rha JH, et al. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke. Stroke. 2016 Sep;47(9):2323–30.

Kim JT, Park MS, Choi KH, Cho KH, Kim BJ, Park JM, et al. Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke. Stroke. 2019 Nov;50(11):3147–55.